RFL Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 18, 2026
Report Source: 2026 2nd Quarter Report
Rafael Holdings Inc. Stock Analysis RFL
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 21 full-time employees. The company went IPO on 2018-03-12. The firm's segments include Healthcare, Infusion Technology and Real Estate. The Company’s lead candidate is Trappsol Cyclo, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder. The Healthcare segment comprises equity interests in LipoMedix Pharmaceuticals Ltd., Barer Institute Inc., Cornerstone Pharmaceuticals, Inc., Cyclo, and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which comprise a portion of one commercial building in Israel. The Infusion Technology segment comprises equity interests in Day Three Labs, Inc. LipoMedix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company.
Read More Rafael Holdings Inc (RFL) Chart
Key Statistics of Rafael Holdings Inc (RFL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.33Volume
28.13KP/E Ratio (TTM)
-52 Week Range
Market Cap
66.07MAvg. Volume
80.80KDividend Yield
-Financial Metrics & Statements of Rafael Holdings Inc (RFL)
FAQ's for Rafael Holdings Inc (RFL)
- According to Musaffa’s Shariah screening methodology, Rafael Holdings Inc (RFL) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.